NO
DGX icon

Ninety One’s Quest Diagnostics DGX Stock Holding History

Ninety One’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,579
Closed -$618K – 78
2017
Q3 		$618K Buy
6,579
+5,817
+763% +$618K 0.33% 45
2017
Q2 		$85K Hold
762
– – 0.05% 65
2017
Q1 		$75K Hold
762
– – 0.05% 66
2016
Q4 		$70K Sell
762
-75
-9% -$6.46K 0.05% 65
2016
Q3 		$70K Buy
837
+116
+16% +$9.74K 0.04% 75
2016
Q2 		$58K Buy
+721
New +$54.9K 0.05% 37

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Ninety One's DGX Position: Q4 2017 in Review

Ninety One sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 6,579 shares — an estimated $618K sold.

Ninety One first reported a position in DGX in Q2 2016 and held it in 6 quarters. The position peaked at $618K in Q3 2017. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • Ninety One reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
  • Ninety One sold 6,579 Quest Diagnostics shares in Q4 2017, an estimated $618K.
  • Ninety One first reported a position in Quest Diagnostics in Q2 2016 and held it in 6 quarters.
  • Ninety One's Quest Diagnostics position peaked at $618K in Q3 2017.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on Ninety One's 13F filing for Q4 2017, filed 13 Feb 2018.